Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Syros Pharmaceuticals, Inc. | a2228976zex-5_1.htm |
| EX-3.1 - EX-3.1 - Syros Pharmaceuticals, Inc. | a2228976zex-3_1.htm |
| EX-1.1 - EX-1.1 - Syros Pharmaceuticals, Inc. | a2228976zex-1_1.htm |
| S-1/A - S-1/A - Syros Pharmaceuticals, Inc. | a2228976zs-1a.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated April 18, 2016 (except for Note 16(B), as to which the date is June 20, 2016), in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-211818) and related Prospectus of Syros Pharmaceuticals, Inc. dated June 20, 2016.
| /s/ Ernst & Young LLP |
Boston,
Massachusetts
June 20, 2016
Consent of Independent Registered Public Accounting Firm